Stockscreener 앱 받기
5.22
4.22%
-0.23
시간 외 거래:
5.38
0.16
+3.07%
Larimar Therapeutics Inc 주식(LRMR)의 최신 뉴스
Larimar Therapeutics Launches $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Global Legal Chronicle
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March - The Manila Times
Larimar Therapeutics price target raised to $12 from $11 at Wedbush - Yahoo Finance
FDA Grants Breakthrough Status to Larimar’s Nomlabofusp - MyChesCo
Wedbush Maintains Outperform on Larimar Therapeutics, Inc. (LRMR) March 2026 - Meyka
LRMR Stock Rating Maintained Outperform by Wedbush, Price Target - GuruFocus
Wedbush raises Larimar Therapeutics stock price target to $12 By Investing.com - Investing.com Canada
Wedbush raises Larimar Therapeutics stock price target to $12 - Investing.com
Larimar Therapeutics (NASDAQ:LRMR) Price Target Raised to $12.00 - MarketBeat
Larimar Therapeutics Stock (LRMR) Opinions on Public Offering and Insider Purchases - Quiver Quantitative
LRMR News & Events - Intellectia AI
Larimar Therapeutics: Deerfield entities buy $25m in stock By Investing.com - Investing.com South Africa
Larimar Therapeutics: Deerfield entities buy $25m in stock - Investing.com Australia
James Flynn Acquires 5,000,000 Shares of Larimar Therapeutics (NASDAQ:LRMR) Stock - MarketBeat
Insider Buying: Frank Thomas Acquires Additional Shares of Larimar Therapeutics Inc (LRMR) - GuruFocus
Wedbush Adjusts Larimar Therapeutics PT to $12 From $11, Maintains Outperform Rating - marketscreener.com
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed? - Yahoo Finance
Larimar Therapeutics Announces Upsized Public Equity Offering - TipRanks
Larimar Therapeutics Prices $5.00 Public Offering, Nets ~$107.6 Million as Option Is Exercised - TradingView
LRMR Should I Buy - Intellectia AI
Larimar Therapeutics prices $100M stock offering at $5 per share - Investing.com Australia
Larimar Therapeutics Prices Upsized $100 Million Public Stock Offering - marketscreener.com
Larimar Therapeutics stock falls 8% on upsized $100 million offering By Investing.com - Investing.com Canada
What is Lifesci Capital's Estimate for LRMR FY2025 Earnings? - MarketBeat
Larimar Therapeutics Prices Upsized 20 Mln Public Offering At $5.00 Per Share, Stock Down - Nasdaq
Larimar Therapeutics (LRMR) Upsizes Public Offering to Raise $10 - GuruFocus
Larimar Therapeutics announces pricing of upsized $100 million underwritten public offering - marketscreener.com
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy - Stocktwits
LRMR Expands Offering to $100 Million - GuruFocus
Larimar Therapeutics Prices Upsized Public Offering - Intellectia AI
Larimar Therapeutics, Inc. Prices Upsized Public Offering of 20 Million Shares at $5.00 Each - Quiver Quantitative
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - Stock Titan
Larimar Therapeutics launches $75M public stock offering By Investing.com - Investing.com Australia
Larimar Therapeutics Announces Pricing Of Upsized $100 Million Underwritten Public Offering - TradingView
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - Benzinga
Larimar Therapeutics launches proposed $75 million public offering - MSN
Press Release: Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - 富途牛牛
Larimar Therapeutics launches $75M public stock offering - Investing.com
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - Bitget
Rare-disease biotech Larimar seeks $75M to fund key drug - Stock Titan
Citigroup Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $14.00 - MarketBeat
LRMR Analyst Update: Citigroup Raises Price Target for Larimar T - GuruFocus
Laminar Therapeutics Stock Is Popping Today: What's Going On? - Benzinga
Larimar Therapeutics (NASDAQ:LRMR) Hits New 1-Year High After Analyst Upgrade - MarketBeat
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Larimar Therapeutics Sees Unusually High Options Volume (NASDAQ:LRMR) - MarketBeat
Larimar’s Stock Soars After FDA Grants Breakthrough Therapy Designation - StocksToTrade
LRMR: Wedbush Reiterates Outperform Rating at $11 | LRMR Stock N - GuruFocus
Larimar Therapeutics' (LRMR) Outperform Rating Reaffirmed at Wedbush - MarketBeat
Lifesci Capital Upgrades Larimar Therapeutics (NASDAQ:LRMR) to "Strong-Buy" - MarketBeat
Why did Larimar Therapeutics’ stock surge over 30% pre-market today? - MSN
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? - Stocktwits
FDA Grants Breakthrough Therapy Designation to Larimar's Nomlabofusp for Friedreich’s Ataxia - Intellectia AI
Biotech and Big Tech Drive the Morning Narrative - Investing News Network
Tuesday Sector Leaders: Biotechnology, Semiconductors - Nasdaq
Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
3.69%
0.68%
자본화:
|
볼륨(24시간):